According to Vision Research Reports, the global electron beam linear accelerators market size surpassed at US$ 330 Mn in 2019 and is expected to expand at a moderate CAGR from 2020 to 2030.
The global electron beam linear accelerators market size is expected to reach US$ 1 billion by 2027. Increase in incidence and prevalence of skin & breast cancer, adoption of electron beam intraoperative radiation therapy (IORT) for treatment of breast cancer, favorable insurance coverage for electron beam linear accelerators, surge in recommendation for electron beam therapy are anticipated to propel the global electron beam linear accelerators market.
Electron beam linear accelerators are innovative particle accelerators, which use high energy X-rays or electrons to locate and conform tumor shape, consequently destroying cancer cells. The global electron beam linear accelerators market is driven by the adoption of innovative electron beam linear accelerators, developments in radiation therapy, ongoing clinical trials, and increase in recommendation of electron beam therapy for cancer treatment. North America dominated the global electron beam linear accelerators market in 2019, followed by Europe and Asia Pacific. North America’s dominance can be ascribed to technological advancements, adoption of radiation therapy, and rise in incidence & prevalence of skin and breast cancers.
Rise in Prevalence of Skin and Breast Cancer to Drive Global Market
Skin cancer is the most common form of cancer. According to the American Cancer Society, melanoma accounts for only about 1% of skin cancers. However, it leads to majority of skin cancer deaths. Around 100,350 new melanoma cases are projected to be diagnosed in the U.S. in 2020; of these, 60,190 will be diagnosed in men and 40,160 in women. According to observations by the American Cancer Society, the number of melanoma cases has been rising rapidly over the last few decades. The World Cancer Research Fund International states that melanoma is the 19th most common type of cancer found in men and women. In 2018, there were about 300,000 new cases across the globe.
The Centers for Disease Control and Prevention (CDC) confirms that breast cancer is the most common in women. In 2017, breast cancer accounted for 30% of all types of newly diagnosed cancers among women. According to the American Cancer Society, nearly 252,710 new cases of cancer were diagnosed in the U.S. in 2017 and the incidence is expected to increase substantially over the next few years. Breastcancer.org highlights that nearly 3.1 million women in the U.S. had a history of breast cancer as of January 2018. The organization stated that nearly 266,120 new cases of invasive breast cancer were diagnosed in the U.S. in 2018.
The prevalence of breast cancer is rising in Europe and Asia Pacific. According to the Cancer Research UK, breast cancer accounted for 15% of newly diagnosed cancer cases in the U.K. Additionally, breast cancer has become a major health concern in Asia Pacific. Therefore, rise in prevalence of skin and breast cancers is projected to boost the electron beam linear accelerators market.
Electron Beam Therapy Overcomes Shortcomings of Megavoltage LINACs in Dermatology
The superficial electron therapy is being highly publicized for the treatment of skin cancer. Since surgery leads to medical contraindications for many patients, manufacturers in the electron beam linear accelerators market are increasing their production capacities for machines. Most patients prefer an active lifestyle and have potential cosmetic concerns pertaining to surgery. This is fueling the demand for electron beam linear accelerators that are non-invasive and convenient.
High cost and complexity of megavoltage LINACs are being overcome with patient accessibility toward the electron beam therapy. Companies in the electron beam linear accelerators market are introducing proprietary technologies to overcome the shortcomings of full scale LINACs. Electron beam LINACs are minimizing the cost of particle therapy, whilst reducing the device footprint. Innovative electron beam LINACs are adapting to a dermatologist’s existing practice workflow.
Improved Testing Capabilities Help Eliminate Issues of Low Emittance Beam Generation
The business of electron beam linear accelerator machines is estimated to reach US$ 1 Bn by the end of 2030. However, equipment manufacturers need to address issues of low emittance beam generation and electron cloud collective instabilities. Manufacturers in the electron beam linear accelerators market can achieve this by increasing their testing capabilities to create availability for quality machines.
Companies in the electron beam linear accelerators market are increasing their focus in remanufacturing and repairing of machines. For instance, Altair— a manufacturer of linear accelerators (LINACs), is offering custom solutions to innovate in electron beam linear accelerators. In order to gain a competitive edge over other manufacturers, companies are delivering turnkey solutions in machines that deploy various energy outputs. Investments in testing and tuning facilities are emerging as a recurring trend of established market players.
The global electron beam linear accelerators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global electron beam linear accelerators market in 2019, followed by Europe and Asia Pacific. Presence of prominent companies operating in the market, recent advancement in radiation therapy, and increase in availability of radiation therapy are factors projected to drive the market in North America. Furthermore, adoption of electron beam linear accelerators coupled with modern comprehensive cancer management of patients at healthcare centers is projected to fuel the growth of the market in the U.S.
The electron beam linear accelerators market in Europe is anticipated to expand at a high CAGR from 2020 to 2030.The market is the region is driven by increase in incidence of skin and breast cancer, surge in expenditure on radiation therapy by hospitals, and rise in number of healthcare centers providing skin cancer diagnosis and treatment services. High quality radiation oncology services for patients in healthcare centers and increase in the number of healthcare centers using the electron beam radiation therapy for the treatment of patients are projected to accelerate the growth of the market during the forecast period in Europe.
Agreements and Merger & Acquisitions among Key Strategies Being Adopted in Global Market
The global electron beam linear accelerators market is consolidated in terms of number of players. The market is dominated by few key players, including Varian Medical Systems, Inc., IntraOp Medical, Inc., and S.I.T. Sordina IORT Technologies S.p.A. Partnerships, contracts, merger & acquisitions, and innovative product approvals boost companies presence in the global electron beam linear accelerators market.
In March 2020, Varian announced that a notice of intent to grant a sole source contract to Varian Medical Systems, Inc. for an order of 12 medical LINACs was filed by the Quebec Government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ). In May 2020, Varian Medical Systems entered into a partnership with the National University Cancer Institute, Singapore (NCIS) to expand access to cancer solutions in Singapore.
By End User
Orthopedic Soft Tissue Repair Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Coagulation Analyzer Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biological Implants Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Automated Dispensing Machines Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Neurodiagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...